Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity. - Wikidata - awgldk - TriplyDB

Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.

Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.

http://www.wikidata.org/entity/Q38196732

about

Calcitonin gene-related peptide: physiology and pathophysiology Anti-CGRP monoclonal antibodies in migraine: current perspectives.Therapeutic antibodies against CGRP or its receptor A second trigeminal CGRP receptor: function and expression of the AMY1 receptor.Taking the headache out of migraine.Experimental inflammation following dural application of complete Freund's adjuvant or inflammatory soup does not alter brain and trigeminal microvascular passage.The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis.CGRP antagonists and antibodies for the treatment of migraine.Novel strategies for the treatment of migraine attacks via the CGRP, serotonin, dopamine, PAC1, and NMDA receptors.Emerging drugs for migraine treatment.Drug safety and tolerability in prophylactic migraine treatment.CGRP mechanism antagonists and migraine management.Optimizing Central Nervous System Drug Development Using Molecular Imaging.Targeting CGRP: A New Era for Migraine Treatment.The Journey to Establish CGRP as a Migraine Target: A Retrospective View.Can aging be 'drugged'?Challenges to develop novel anti-inflammatory and analgesic drugs.CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment.[EXPRESS] Monoclonal antibodies for chronic pain: a practical review of mechanisms and clinical applications.Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study.CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured.CGRP and its receptors.Behavioral effects and mechanisms of migraine pathogenesis following estradiol exposure in a multibehavioral model of migraine in rat.

P2860

Q28249298-B2497C3F-042C-4F4F-BE1E-5AA66FB4FFEC Q34531880-B9AD0EEC-AD51-4060-84A7-EFCC60767A76 Q35684794-E9D17353-F7E4-46C9-9461-D2BC8F8A4877 Q35777253-0B114613-AD82-4C51-A623-56E14173CB52 Q35996556-3B96A480-8FD7-4E8E-BE64-AAD04A4CF09D Q36233055-0B48860A-A48C-4E75-91E5-34666E00D583 Q36340711-318D05BE-66C5-4DE0-AD5A-7FD8D107F04C Q38248953-7335F84E-B5AA-4D00-A782-CD10B2E913ED Q38254099-84C9274B-8106-45CE-927B-EBBD52AE5575 Q38303376-3C90DB97-3A28-44A9-8075-3DD6206C4251 Q38353242-47C8F6A6-9476-4A2A-9266-A88E0925CC3D Q38384223-52F78DEA-1563-4EE7-B831-2C8F0CB76B89 Q38419418-E9D1BACC-1392-4B2A-BE97-5AA6DE37113C Q38542176-B0D08AE8-E901-40CE-B418-FC17BF69BA20 Q38561443-92350822-88AE-4D51-B8FB-F6879BEB15FC Q38662550-26027405-C88E-43C6-9830-86AE6004CE8B Q38941483-00389C25-E639-4742-9AE7-C54096AB8ABF Q39193269-A6B72A6F-22EE-448B-AB67-308D01E585D8 Q46156381-9CC02BA6-3E87-4029-9479-51FC5AE42B11 Q47663546-90321436-AAE4-423D-B12D-CF4D969F75A0 Q47976301-5D3DF996-2FEC-4D68-85E1-8AB967190C26 Q48198655-F006A6CC-03B4-4808-939A-CD4068FA0CA2 Q50195658-829D0980-3BE3-476B-962A-1D800951C660

P2860

Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.

http://www.wikidata.org/entity/Q38196732

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.

@en

type

label

Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.

@en

prefLabel

Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.

@en

P1433

Q38196732-35B0A5A5-A924-487A-B577-C2687C0EA8ED

P1476

Q38196732-5F3B2AE3-2AC0-4D11-B0EF-2E8997FE339B

P2093

Q38196732-EDE14508-71E0-45C1-94D1-6D61FE97C805

P2860

Q38196732-01619826-7A07-400E-9958-0B2EDA1C8CCE

Q38196732-06EB4625-E810-4C1F-BB74-E71C673907FA

Q38196732-10ABA91C-BB29-4955-B89B-A4F9F41BA867

Q38196732-13CBFAC1-667D-4D0F-855C-25EF4D8DA34E

Q38196732-15035F2E-C9E2-4473-AF7B-53F0714F0099

Q38196732-178D31BE-8746-40A5-86EC-CE734A5390B8

Q38196732-18437CF8-A1B7-445C-83B3-44B680CB0051

Q38196732-18D724DD-5C48-41B0-BA93-8C48B8EC81C3

Q38196732-1DFCAA7F-F289-4CC7-9423-7E17C8184267

Q38196732-1EF528B8-157A-42EC-A04E-F420D54B1E32

P2888

Q38196732-1A6BCD37-B2C0-4504-8917-2C3898480021

P304

Q38196732-9A30B358-6698-411A-AEAD-D4418C722E55

P31

Q38196732-3A27BBAD-814A-4B5F-AAB8-5E0330886467

P356

Q38196732-4E57E925-3B1A-45B5-80E9-15D4274591EA

P433

Q38196732-8F155373-C24B-492A-BCA1-3FCC7F16474A

P478

Q38196732-F90745E8-C89B-4CA5-8706-6927520946D6

P50

Q38196732-C2E70F2E-CFFB-4A0B-9EBC-837540E50258

P577

Q38196732-7484BF93-2368-4507-876D-BD9BFC9C246A

P5875

Q38196732-8DE097BE-CF20-45BD-97FC-8E3704D637B3

P698

Q38196732-594FF4B6-F341-43C3-8665-FEA9E8BFF475

P921

Q38196732-544E6073-49FB-449C-8E7D-45F0A556E578

Q38196732-86E038FA-0A4D-4A08-B7E5-5EC253A42724

P356

S40263-014-0156-4

P1433

P1476

Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.

@en

P2093

Sarah Walter

http://www.w3.org/2001/XMLSchema#string

P2860

Calcitonin gene-related peptide: functional role in cerebrovascular regulation

Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study

CGRP may play a causative role in migraine

Early development of therapeutic biologics--pharmacokinetics.

Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation.

Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine.

Evolution of the CT/CGRP family: comparative study with new data from models of teleosts, the eel, and cephalopod molluscs, the cuttlefish and the nautilus.

Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist.

Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat.

Possible sites of action of the new calcitonin gene-related peptide receptor antagonists.

P2888

s40263-014-0156-4

P304

389-399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40263-014-0156-4

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Marcelo E Bigal

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260875694

http://www.w3.org/2001/XMLSchema#string

P698

24638916

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder